J. Bergeron

Molecular properties of monoamine oxidases A and B

C. Abell, S. Kwan, J. Bergeron, 2005, Psychopharmacology.

A phase 2 trial of the efficacy and safety of evinacumab in patients with severe hypertriglyceridemia

D. Gaudet, D. Rader, C. Ballantyne, 2021, Atherosclerosis.

ARO-ANG3, an investigational RNAI therapeutic, decreases serum LDL-cholesterol, apolipoprotein B, and angiopoietin-like protein 3 in patients with homozygous familial hypercholesterolaemia

D. Gaudet, J. Hamilton, F. Raal, 2023, Atherosclerosis.